Literature DB >> 8891115

Role of protein kinase C-beta isozyme in activation of latent human immunodeficiency virus type 1 in promonocytic U1 cells by phorbol-12-myristate acetate.

C H Kim1, S Gollapudi, A Kim, T Lee, S Gupta.   

Abstract

Protein kinase C (PKC) appears to play a role in replication of human immunodeficiency virus type 1 (HIV-1). PKC is a family of at least 12 isozymes. In this study, we investigated a role of Ca(2+)-dependent PKC isozymes (alpha, beta, and gamma) in activation of latent HIV-1 in U1, a chronically infected promonocytic cell line, using polyclonal rabbit anti-PKC isozyme antibodies as specific inhibitors. Antibodies were introduced intracellularly by electroporation and then cells were stimulated with PMA. HIV-1 production was measured as p24 antigen using ELISA and reverse transcriptase activity. Anti-PKC beta antibody significantly inhibited PMA-induced HIV-1 production, whereas antibodies against PKC alpha and gamma had no significant effect. Furthermore, anti-PKC beta antibody inhibited PMA-induced activation of NF-kappa B and HIV-1 LTR. Preincubation of anti-PKC beta antibody with its antigenic peptide reversed the inhibitory effect of anti-PKC beta antibody. This study suggest that PKC beta plays a role in PMA-induced activation of latent HIV-1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8891115     DOI: 10.1089/aid.1996.12.1361

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  7 in total

1.  Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity.

Authors:  Theresa L Chang; Jesus Vargas; Armando DelPortillo; Mary E Klotman
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

2.  Macrophage colony stimulating factor regulation by nuclear factor kappa B: a relevant pathway in human immunodeficiency virus type 1 infected macrophages.

Authors:  Michael Kogan; Valerie Haine; Yuxong Ke; Brian Wigdahl; Tracy Fischer-Smith; Jay Rappaport
Journal:  DNA Cell Biol       Date:  2011-09-06       Impact factor: 3.311

3.  Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency.

Authors:  Olaf Kutsch; Etty N Benveniste; George M Shaw; David N Levy
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 4.  Targeting NF-κB signaling with protein kinase C agonists as an emerging strategy for combating HIV latency.

Authors:  Guochun Jiang; Satya Dandekar
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

5.  Antioxidant nanozyme counteracts HIV-1 by modulating intracellular redox potential.

Authors:  Shalini Singh; Sourav Ghosh; Virender Kumar Pal; MohamedHusen Munshi; Pooja Shekar; Diwakar Tumkur Narasimha Murthy; Govindasamy Mugesh; Amit Singh
Journal:  EMBO Mol Med       Date:  2021-04-01       Impact factor: 12.137

6.  PKC phosphorylates HEXIM1 and regulates P-TEFb activity.

Authors:  Koh Fujinaga; Matjaz Barboric; Qintong Li; Zeping Luo; David H Price; B Matija Peterlin
Journal:  Nucleic Acids Res       Date:  2012-07-20       Impact factor: 16.971

7.  Measuring glutathione redox potential of HIV-1-infected macrophages.

Authors:  Ashima Bhaskar; MohamedHusen Munshi; Sohrab Zafar Khan; Sadaf Fatima; Rahul Arya; Shahid Jameel; Amit Singh
Journal:  J Biol Chem       Date:  2014-11-18       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.